Description
SLAMF7 (Signaling Lymphocytic Activation Molecule Family member 7) is a cell surface protein that belongs to the signaling lymphocytic activation molecule (SLAM) family. It is primarily expressed on natural killer (NK) cells, a type of immune cell that plays a crucial role in targeting and killing infected or cancerous cells. SLAMF7 is also found on other immune cells, such as certain T cells and dendritic cells.
Specifications
|
Synonyms |
CD2 subset 1, CRACC, CD319, CS1, Novel Ly9, SLAMF7, 19A, FOAP-12 |
|
Uniprot No. |
Q9NQ25-1 |
|
Source |
Recombinant Human SLAMF7/CRACC/CD319 Protein is expressed from HEK293 Cells with His tag at the C-terminal. It contains Ser23-Met226. |
|
Molecular Weight |
The protein has a predicted MW of 24.33 kDa. And it migrates as 30-55 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation. |
|
Purity |
> 90% as determined by SDS-PAGE. |
|
Endotoxin |
< 1 EU per 1 μg of the protein by the LAL method. |
|
Formulation |
Liquid in PBS. |
Storage
The product should be stored at -25~-15℃ for 1 year from date of receipt.
Note
1.Please operate with lab coats and disposable gloves, for your safety.
2.This product is for research use only.
Product Data
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.
Inquiry
You may also like
FAQ
The product is for research purposes only and is not intended for therapeutic or diagnostic use in humans or animals. Products and content are protected by patents, trademarks, and copyrights owned by Yeasen Biotechnology. Trademark symbols indicate the country of origin, not necessarily registration in all regions.
Certain applications may require additional third-party intellectual property rights.
Yeasen is dedicated to ethical science, believing our research should address critical questions while ensuring safety and ethical standards.